<p>(<b>A</b>) DMH1 treatment showed no effect on the protein expressions of PP2A-a, PP2A-b, and PP2A-c subunits. (<b>B</b>) DMH1 treatment inhibited PP2A activity in L6 cells. **<i>P</i><0.01 vs control. (<b>C</b>) PP2A activator forskolin (40 µM) inhibited DMH1-induced Akt activation in L6 cells. **<i>P</i><0.01 <i>vs</i> control. ## <i>P</i><0.01 vs DMH1.(<b>D–E</b>) Forskolin (40 µM) showed no effects on p-AMPK level in L6 cells.</p
A) HeLa NT2 and Δwdr68-21 (Δ21) cells mock (-) or treated with 50μM LLNL for 6 hours. DYRK1A panel: ...
Although substantial studies have begun to explore the regulation of phosphatidylinositol 3-kinase/A...
Although substantial studies have begun to explore the regulation of phosphatidylinositol 3-kinase/A...
<p>(<b>A</b>) DMH1 activated Akt in L6 cells. L6 cells were treated with 1 µM, 5 µM and 10 µM DMH1 f...
<p>(<b>A</b>) Representative western blot results showed that DMH1 did not affect phosphorylation of...
<p>(A) Western blot results showed that compound C inhibited DMH1-induced Akt activation in L6 cells...
<p>(<b>A</b>) DMH1 did not increase LDH release in L6 cells. Cells were incubated with 1 µM, 5 µM an...
<p>Chemical structure of DMH1; (B) Western blotting for phosphorylated Smad1/5/8 in A549 cells treat...
<p>(<b>A</b>) L6 cells were incubated with 0.1 µM,1 µM,5 µM and 10 µM DMH1 for 24 hrs. n = 10. (<b>B...
<p>A. Western blotting was performed to detect activated P-AKT and p-mTOR, total AKT and mTOR in sta...
<p>(A) Effect of DRβ-H on the phosphorylation of PI3K, PDK1, and AKT in MCF-7 and MDA-MB-231 cells. ...
<p>(A) A Western blotting analysis showed that treatment with MTA1 siRNA could inhibit AKT phosphory...
<p>DMH1 activated Akt and increased glucose metabolism; but compound C inhibited DMH1 –induced Akt a...
<p>(A) lysates were prepared from MDA-MB-231, NCI-H358, and HCT 116 wt and SK-1 kd cells, and analyz...
<p>(A) The activation curve for the effect of ZLN024 on the activity of the AMPKα1 truncations (1–39...
A) HeLa NT2 and Δwdr68-21 (Δ21) cells mock (-) or treated with 50μM LLNL for 6 hours. DYRK1A panel: ...
Although substantial studies have begun to explore the regulation of phosphatidylinositol 3-kinase/A...
Although substantial studies have begun to explore the regulation of phosphatidylinositol 3-kinase/A...
<p>(<b>A</b>) DMH1 activated Akt in L6 cells. L6 cells were treated with 1 µM, 5 µM and 10 µM DMH1 f...
<p>(<b>A</b>) Representative western blot results showed that DMH1 did not affect phosphorylation of...
<p>(A) Western blot results showed that compound C inhibited DMH1-induced Akt activation in L6 cells...
<p>(<b>A</b>) DMH1 did not increase LDH release in L6 cells. Cells were incubated with 1 µM, 5 µM an...
<p>Chemical structure of DMH1; (B) Western blotting for phosphorylated Smad1/5/8 in A549 cells treat...
<p>(<b>A</b>) L6 cells were incubated with 0.1 µM,1 µM,5 µM and 10 µM DMH1 for 24 hrs. n = 10. (<b>B...
<p>A. Western blotting was performed to detect activated P-AKT and p-mTOR, total AKT and mTOR in sta...
<p>(A) Effect of DRβ-H on the phosphorylation of PI3K, PDK1, and AKT in MCF-7 and MDA-MB-231 cells. ...
<p>(A) A Western blotting analysis showed that treatment with MTA1 siRNA could inhibit AKT phosphory...
<p>DMH1 activated Akt and increased glucose metabolism; but compound C inhibited DMH1 –induced Akt a...
<p>(A) lysates were prepared from MDA-MB-231, NCI-H358, and HCT 116 wt and SK-1 kd cells, and analyz...
<p>(A) The activation curve for the effect of ZLN024 on the activity of the AMPKα1 truncations (1–39...
A) HeLa NT2 and Δwdr68-21 (Δ21) cells mock (-) or treated with 50μM LLNL for 6 hours. DYRK1A panel: ...
Although substantial studies have begun to explore the regulation of phosphatidylinositol 3-kinase/A...
Although substantial studies have begun to explore the regulation of phosphatidylinositol 3-kinase/A...